Infectious Disease Diagnostics Market to Be Worth $12.88 Billion by 2025 - Exclusive Report by Meticulous Research®
LONDON, July 22, 2019 (Newswire.com) - Meticulous Research® has published its latest market research report on the highly intriguing industry segment “infectious disease diagnostics”, in the past week. The report states that the global infectious disease diagnostics market will increase at a CAGR of 5.9% from 2019 to reach $12.88 billion by 2025, driven by increasing global prevalence of infectious diseases, growing awareness of early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and a shift in focus from centralized laboratories to decentralized point-of-care testing.
The report provides meticulous analysis of this market, by segmenting it on the basis of product and services (consumables, instruments, and software and services), technology (immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarray, and other technologies), disease type (hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases), end-user (hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end-users), and geography.
Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4976
Geographically, North America commanded the largest share in this market, followed by Europe. The major share of North America is mainly attributed to the growing healthcare sector, the increasing need to treat various infectious diseases, increasing healthcare expenditures, growing demand of point-of-care testing, an increase in research and development, coupled with the development of novel advanced technologies for diagnosis and a large patient population. While North America will continue to dominate the global infectious disease diagnostics market, the APAC region is expected to grow at the highest CAGR of 6.9% during the forecast period of 2019 to 2025.
“Improving healthcare infrastructure, rising per capita income, growing healthcare spending, and advancement in the technologies are expected to create greater demand for healthcare services in developing countries across APAC, Latin America, and Middle East and African regions. This, in turn, is expected to drive the demand for the solutions used for the diagnosis of infectious diseases among the healthcare professionals in these regions,” said Uddhav Sable, Research Director at Meticulous Research®.
Among technologies, the immunodiagnostics segment commanded the largest share, majorly due to the increasing use of immunoassays in POC infectious disease testing, the development of novel tests, and the rising trend of automation in immunoassay instruments.
The key players analyzed in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
The report is available for purchase in electronic format with multiple license choices and sectional purchases, starting at only $499.
Authoritative Research on the Infectious Disease Diagnostics Market:
Need more information? Meticulous Research®’s new report covers each of the top market segments in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Request Sample or Check for a Discount: https://www.meticulousresearch.com/request-discount/cp_id=4976
Source: Meticulous Market Research Pvt. Ltd.